Genital herpes - Clinical trials 

  • Genital Herpes - Clinical trials - NHS Choices

Clinical trials for Genital herpes

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Genital herpes. For all clinical trials, go to clinical trials search

This list shows clinical trials for Genital herpes

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Genital herpes
Title Recruitment status Location
The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK) Recruiting United Kingdom
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (Study No. V212-001 AM3) Recruiting United Kingdom
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM1) Recruiting United Kingdom
Study of a Cold Sore Patch for the Treatment of Herpes Labialis Not recruiting United Kingdom
Oral Antiviral Prophylaxis for Prevention of Recurrent Herpes Simplex Infection after Corneal Grafting - A Pilot Study Not recruiting United Kingdom
Clinical Study of Eslicarbazepine Acetate as a Therapy in Post-Herpetic Neuralgia. (Post-herpetic neuralgia is a chronic pain syndrome following an acute infection of herpes zoster (shingles). Not Recruiting United Kingdom
A Double-Blind, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX™ Administered Concomitantly Versus Nonconcomitantly with Influenza Virus Vaccine (Inactivated) - ZOSTAVAX™ Administered Concomitantly with Influenza Vaccine Not Recruiting United Kingdom
Study to Evaluate Using a Cold Sore Patch to Treat Herpes Labialis Not recruiting United Kingdom
Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old Not recruiting United Kingdom
A Phase IV Clinical Trial to Evaluate the Safety and Tolerability of ZOSTAVAX™ in Subjects =60 Years of Age Not Recruiting United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member